Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;23(10):1294-300.
doi: 10.1038/ejhg.2014.301. Epub 2015 Jan 28.

A mixed methods study of age at diagnosis and diagnostic odyssey for Duchenne muscular dystrophy

Affiliations

A mixed methods study of age at diagnosis and diagnostic odyssey for Duchenne muscular dystrophy

Siaw H Wong et al. Eur J Hum Genet. 2015 Oct.

Abstract

The delayed diagnosis of Duchenne muscular dystrophy (DMD) may be an ongoing problem internationally. We aimed to ascertain age at diagnosis and explore parents' experiences of the diagnosis of DMD in Australia. Using mixed methods, data were collected from laboratory and clinical record audits of testing for DMD in Victoria and Tasmania, interviews and a national survey of parents regarding their experiences from first noticing symptoms to receiving a diagnosis. The audits revealed that the median age at diagnosis for DMD was 5 years (n=49 during 2005-2010); this age had not changed substantially over this period. Fourteen parents interviewed reported age at diagnosis ranging from 2 to 8 years with a 6 month to 4 year delay between initial concerns about their child's development and receiving the DMD diagnosis. Sixty-two survey respondents reported the median age at diagnosis was 3 years and 9 months, while the median age when symptoms were noticed was 2 years and 9 months. Parents experienced many emotions in their search for a diagnosis and consulted with a wide range of health professionals. Half the survey respondents felt that their child could have been diagnosed earlier. Despite advances in testing technologies and increasing awareness of DMD, the age at diagnosis has remained constant in Australia. This mixed methods study shows that this diagnostic delay continues to have a negative impact on parents' experiences, places families at risk of having a second affected child and may have a deleterious effect on affected children's treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Audit of clinical and laboratory records: age at DMD diagnosis for all tests ordered 2005–2010 in Victoria and Tasmania (N=49). Median=5 years. (b) Audit of clinical and laboratory records: age at DMD diagnosis for tests ordered by pediatricians and pediatric neurologists (N=42). Median age at diagnosis for tests ordered by paediatricians in tertiary hospitals or paediatric neurologists=4.5 years. Median age at diagnosis for tests ordered by community paediatricians=5 years.

References

    1. 1Emery AE: Population frequencies of inherited neuromuscular diseases–a world survey. Neuromuscul Disord 1991; 1: 19–29. - PubMed
    1. 2Emery AEH, Emery MLH: The History of a Genetic DIsease: Duchenne Muscular Dystrophy or Meryon's DIsease, 1st edn. London: Royal Society of Medicine Press, 1995.
    1. 3Muntoni F, Wells D: Genetic treatments in muscular dystrophies. Curr Opin Neurol 2007; 20: 590–594. - PubMed
    1. 4Bushby K, Finkel R, Birnkrant DJ et al: Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010; 9: 77–93. - PubMed
    1. 5Cyrulnik SE, Fee RJ, De Vivo DC, Goldstein E, Hinton VJ: Delayed developmental language milestones in children with Duchenne's muscular dystrophy. J Pediatr 2007; 150: 474–478. - PMC - PubMed

LinkOut - more resources